Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
reporting on two studies with 80 male subjects
Only 43% of large employers (5,000 or more employees) cover GLP-1s for weight loss
GLP1 (glucagonlike peptide1) therapies that were originally developed to treat Type 2 diabetes, have moved into mainstream conversations about the positive affect GLP-1s have had on weight management
Prescription drug costs are increasing around 13%-15% annually and GLP-1 costs are fueling much of this growth as they currently comprise roughly 20% of total prescription drug costs, according to Aon data
US$ 29.13
US$ 22.47
US$ 20.65
US$ 28.54
US$ 23.88
US$ 25.81
US$ 25.45
US$ 28.69
US$ 20.45
